Literature DB >> 15738291

Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.

S G Van Daele1, H Franckx, R Verhelst, P Schelstraete, F Haerynck, L Van Simaey, G Claeys, M Vaneechoutte, F de Baets.   

Abstract

Pseudomonas aeruginosa is the leading pathogen in cystic fibrosis (CF) lungs. Since there is great concern about clonal spread in CF centres, this study examined the P. aeruginosa genotypes of colonised residents of a CF rehabilitation centre. The isolates from the sputum of 76 P. aeruginosa-colonised patients were genotyped by fluorescent amplified fragment length polymorphism on arrival and departure. A total of 71 different P. aeruginosa genotypes were identified from 749 isolates. Forty-nine patients had one genotype, 20 had two genotypes and seven had three. Forty-four patients had one or more genotypes in common with other patients (i.e. cluster types). Thirty-two patients were colonised by a single genotype not shared by any other patient. Thirty-eight of the 44 patients with a cluster type already carried their cluster type strain(s) on arrival. Patient-to-patient transmission could not be excluded for eight patients. For five of these, this infection was transient. None of the environmental P. aeruginosa isolates had a genotype similar to the patients' genotypes. In summary, most patients were colonised by only one or two P. aeruginosa genotypes and the risk of persistent patient-to-patient transmission was low during the study period (4%). Most patients with a cluster-type strain carried this strain on arrival, indicating that transmission could have happened in the past. No environmental contamination could be established.

Entities:  

Mesh:

Year:  2005        PMID: 15738291     DOI: 10.1183/09031936.05.00050304

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.

Authors:  A Abdul Wahab; S J Taj-Aldeen; F Hagen; S Diophode; A Saadoon; J F Meis; C H Klaassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-01       Impact factor: 3.267

2.  Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Authors:  Don Hayes; Susan E West; Michael J Rock; Zhanhai Li; Mark L Splaingard; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2010-07

3.  Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Authors:  Sabine Van Daele; Rita Verhelst; Geert Claeys; Gerda Verschraegen; Hilde Franckx; Leen Van Simaey; Catharine de Ganck; Frans De Baets; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 4.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

5.  Rehabilitation Programs for Cystic Fibrosis - View from a CF Center.

Authors:  M Griese; P Busch; D Caroli; B Mertens; C Eismann; M Harari; H Staudter; M Kappler
Journal:  Open Respir Med J       Date:  2010-01-07

6.  Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  I Leone; M G Chirillo; T Raso; M Zucca; D Savoia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

7.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

8.  Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.

Authors:  Pieter Deschaght; Thierry De Baere; Leen Van Simaey; Sabine Van Daele; Frans De Baets; Daniel De Vos; Jean-Paul Pirnay; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2009-11-29       Impact factor: 3.605

9.  Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.

Authors:  Diana Bilton; Isabelle Fajac; Tacjana Pressler; John Paul Clancy; Dorota Sands; Predrag Minic; Marco Cipolli; Ivanka Galeva; Amparo Solé; Alexandra L Quittner; Zhanna Jumadilova; Monika Ciesielska; Michael W Konstan
Journal:  J Cyst Fibros       Date:  2021-06-16       Impact factor: 5.527

10.  Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran.

Authors:  Hossein Fazeli; Reza Akbari; Sharare Moghim; Bahram Nasr Esfahani
Journal:  Adv Biomed Res       Date:  2013-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.